A detailed history of Exodus Point Capital Management, LP transactions in Abb Vie Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 1,600 shares of ABBV stock, worth $288,000. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,600
Previous 23,700 93.25%
Holding current value
$288,000
Previous $4.07 Million 92.23%
% of portfolio
0.0%
Previous 0.03%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$163.84 - $199.33 $6.14 Million - $7.47 Million
37,472 New
37,472 $7.4 Million
Q3 2023

Nov 09, 2023

SELL
$133.59 - $154.65 $12.4 Million - $14.4 Million
-92,885 Reduced 28.75%
230,193 $34.3 Million
Q2 2023

Aug 10, 2023

BUY
$132.51 - $164.9 $26.9 Million - $33.5 Million
202,892 Added 168.82%
323,078 $43.5 Million
Q1 2023

May 11, 2023

BUY
$144.61 - $166.54 $17.1 Million - $19.7 Million
118,218 Added 6007.01%
120,186 $19.2 Million
Q4 2022

Feb 13, 2023

BUY
$138.31 - $165.87 $272,194 - $326,432
1,968 New
1,968 $318,000
Q3 2022

Nov 10, 2022

SELL
$134.21 - $153.93 $5.76 Million - $6.61 Million
-42,941 Closed
0 $0
Q2 2022

Aug 19, 2022

BUY
$137.62 - $174.96 $2.86 Million - $3.64 Million
20,795 Added 93.9%
42,941 $6.58 Million
Q1 2022

May 13, 2022

BUY
$131.98 - $163.75 $2.92 Million - $3.63 Million
22,146 New
22,146 $3.59 Million
Q4 2021

Feb 11, 2022

SELL
$107.43 - $135.93 $8.38 Million - $10.6 Million
-77,978 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $4.85 Million - $5.51 Million
45,610 Added 140.91%
77,978 $8.41 Million
Q2 2021

Aug 16, 2021

SELL
$105.21 - $117.21 $6.55 Million - $7.29 Million
-62,225 Reduced 65.78%
32,368 $3.65 Million
Q1 2021

May 17, 2021

BUY
$102.3 - $112.62 $1.42 Million - $1.56 Million
13,865 Added 17.17%
94,593 $10.2 Million
Q4 2020

Feb 16, 2021

BUY
$80.49 - $108.67 $4.76 Million - $6.43 Million
59,192 Added 274.85%
80,728 $8.65 Million
Q3 2020

Nov 16, 2020

SELL
$85.91 - $100.83 $617,864 - $725,169
-7,192 Reduced 25.03%
21,536 $1.89 Million
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $2.11 Million - $2.82 Million
28,728 New
28,728 $2.82 Million
Q1 2020

May 15, 2020

SELL
$64.5 - $97.79 $1.74 Million - $2.64 Million
-26,984 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$72.13 - $90.25 $716,683 - $896,724
-9,936 Reduced 26.91%
26,984 $2.39 Million
Q3 2019

Nov 14, 2019

BUY
$62.98 - $75.72 $1.64 Million - $1.97 Million
26,008 Added 238.34%
36,920 $2.8 Million
Q2 2019

Aug 14, 2019

BUY
$65.7 - $83.98 $716,918 - $916,389
10,912 New
10,912 $794,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.